The introduction of nicotinamide to be a nicotine substitute in e-cigarette and smokeless products represents a significant regulatory obstacle with the FDA. Nicotinamide doesn't have nicotinic receptor agonist exercise and is understood to work as a sedative at higher dosages6. The promises made by Nicotine River, ECBlend, and various vendors that